Trademark Overview
On Friday, January 21, 2022, a trademark application was filed for TMCI with the United States Patent and Trademark Office. The USPTO has given the TMCI trademark a serial number of 97232320. The federal status of this trademark filing is REGISTERED as of Tuesday, February 21, 2023. This trademark is owned by Texas Medical Center. The TMCI trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Education & Entertainment Services categories with the following description:
Business education and training services, namely, conducting education and training programs in the fields of market research, FDA regulations, intellectual property, licensing, venture capital funding, finance, fundraising, legal and the fundamentals necessary to transform ideas into products and products into start-up companies for entrepreneurs and companies in the digital health, medical device, and cancer therapeutics industries; Educational services, namely, mentoring in the fields of transforming ideas into products, product commercialization, starting up a business, and transforming products into start-up companies for entrepreneurs and companies in the digital health, medical device, and cancer therapeutics industries
Rental and leasing of offices for co-working; Rental and leasing of office space
Business organization, development, management, and consulting services to companies and entrepreneurs in the digital health, medical devices, and cancer therapeutics industries; Rental and leasing of office equipment; Promoting collaboration within the scientific, research, medical and pharmaceutical communities to achieve advances in the fields of medicine, health care, science and biomedical engineering for human performance; Promoting public awareness of the need for collaboration within the scientific, research, medical and pharmaceutical communities to achieve advances in the fields of medicine, health care, science and biomedical engineering for human performance; excluding from all of the foregoing, the provision of medical services and the performance of clinical trials or clinical research
